CRH Public Ltd Co (CRH) stock analysis
Close on Nov 12, 2026Market cap $62.48BP/E 17.7Yield 1.58%
StockData Score
Prices as of Nov 12, 2026How the score works
Solid15 of 30 checks passed
CRH Public passes 15 of the 30 checks behind our score; 2 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 4/6
- Growth
- 2/6
- Past performance
- 4/6
- Financial health
- 3/6
- Dividend
- 2/6
What stands out
Trading below fair value
The share price of $96.26 is below our fair value estimate of $102.04.
Return on capital over 10%
Return on invested capital was 10.0%, above the 10% that usually covers the cost of capital.
Earnings grew over 5 years
Net income grew 27.3% a year on average over the last five fiscal years.
Interest well covered
Operating income covers interest expense 6.3 times.
What to watch
Margin of safety under 20%
The price is 5.7% below fair value, less than the 20% cushion we look for.
Return on equity under 15%
Return on equity was 14.8% over the last twelve months and averaged 15.8% over five years; we look for 15% on both.
High debt
Debt is 78.5% of shareholders' equity, above the 40% we consider low.
Revenue growing under 10% a year
Revenue grew 4.6% a year over the last three fiscal years, short of the 10% we look for.
Valuation4/6
P/E below its 5-year median
CRH Public's P/E of 18.1 is below its own 5-year median of 19.3.
P/E below the industry
CRH Public's P/E of 18.1 is below the Materials median of 21.3.
EV/EBITDA below its 5-year median
CRH Public's EV/EBITDA of 10.5 is below its 5-year median of 12.0.
P/B above the industry
CRH Public's price-to-book of 2.56 is above the Materials median of 2.33.
Trading below fair value
The share price of $96.26 is below our fair value estimate of $102.04.
Margin of safety under 20%
The price is 5.7% below fair value, less than the 20% cushion we look for.
Growth2/6
Revenue growing under 10% a year
Revenue grew 4.6% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew 2.5% a year over the last three fiscal years.
Earnings growth not accelerating
Net income grew 4.3% over the last twelve months, against a 5-year average of 27.3% a year.
Growing faster than the industry
Revenue grew 5.6% over the last twelve months; the Materials median is 2.3%.
Guidance lowered
CRH Public lowered its 2026 Capital expenditure outlook on Jul 30, 2026.
Gross margin improving
Gross margin was 36.2% over the last twelve months, against 36.1% a year earlier.
Past performance4/6
Return on equity under 15%
Return on equity was 14.8% over the last twelve months and averaged 15.8% over five years; we look for 15% on both.
Return on capital over 10%
Return on invested capital was 10.0%, above the 10% that usually covers the cost of capital.
Return on equity above the industry
CRH Public's return on equity of 14.8% is above the Materials median of 5.1%.
Earnings grew over 5 years
Net income grew 27.3% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 9.2% over the last twelve months, against a 5-year average of 9.9%.
Net margin above the industry
CRH Public's net margin of 9.2% is above the Materials median of 2.8%.
Financial health3/6
High debt
Debt is 78.5% of shareholders' equity, above the 40% we consider low.
Debt rising against equity
Debt to equity rose from 62.1% five years ago to 78.5%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 26.4% of total debt.
Interest well covered
Operating income covers interest expense 6.3 times.
Short-term assets cover short-term debts
Current assets are 1.46 times current liabilities.
Bankruptcy risk in the grey zone
The Altman Z-score is 2.74; above 3 is the safe zone and below 1.8 the distress zone.
Dividend2/6
Pays a dividend
CRH Public paid dividends worth 1.2% of the share price over the last twelve months.
Yield below Treasuries
The 1.2% yield is below the 4.6% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.9% or more; CRH Public yields 1.2%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 5 fiscal years.
Earnings cover
Needs dividends paid and net income.
Cash-flow cover
Needs dividends paid and free cash flow.
Fair value
How we estimate itOur estimate per share
$102.04
The share price is 6% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 20.7× | 19.3× | 21.3× | $110.29 | 40% |
| EV/EBITDA | 12.1× | 12.0× | 12.2× | $117.07 | 35% |
| P/B | 2.6× | 3.2× | 2.3× | $96.83 | 10% |
| Earnings power | 10.4% cost of equity | – | – | $48.44 | 15% |
| Fair value | $102.04 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 19.3
- Materials median 21.3
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $487.14M
- Value traded per 1% price move
- $305.15M
Downside
Medium risk
- Typical loss in a bad month
- 18.1%
- Volatility (annualized)
- 34%
- Sharpe ratio, 1 year
- -0.59
- Beta to the S&P 500 (5Y)
- 1.08
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2015 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +5.3% | +4.6% | +7.7% | – | |
| Gross profit | +6.5% | +7.7% | +9.6% | – | |
| Operating income | +10.5% | +12.6% | +21.8% | – | |
| Net income | +7.5% | -0.9% | +27.3% | – | |
| EPS, diluted | +9.8% | +2.5% | +31.2% | – | |
| Free cash flow | +20.8% | +8.5% | -0.2% | – | |
| Dividend per share | +5.7% | +5.2% | – | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | 5.8% | 16.5% | |
| Return on assets | – | 2.4% | 6.9% | |
| Current ratio | – | 2.01 | 1.74 | |
| Debt to equity | – | 0.62 | 0.74 | |
| Net debt to EBITDA | – | – | 1.78× | |
| Interest coverage | – | 4.6× | 6.7× | |
| Inventory turnover | – | 5.6× | 4.8× | |
| Capex to revenue | – | 3.8% | 7.2% | |
| Diluted shares | 834M | 791M | 677M |
Where the cash went
Fiscal 2021 to 2025, five years combined
CRH Public generated $23.41B from operations and spent $19.86B on capital expenditure, dividends and share buybacks. 51% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 10.0% | 0.69× | 2.39× | 16.5% |
| FY2024 | 9.8% | 0.73× | 2.31× | 16.4% |
| FY2023 | 9.1% | 0.75× | 2.16× | 14.8% |
| FY2022 | 11.8% | 0.73× | 2.12× | 18.2% |
| FY2021 | 9.0% | 0.65× | 2.25× | 13.2% |
| FY2020 | 4.3% | 0.56× | 2.39× | 5.8% |
| FY2019 | 6.1% | 0.60× | 2.53× | 9.2% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$3.75B
- Cash generatingOperating cash flow above zero$5.63B
- Return on assets improvedROA up on the prior year7.4% → 7.4%
- Earnings backed by cashOperating cash flow above net income$5.63B vs $3.75B
- Less leverageLong-term debt to assets fell21.7% → 28.3%
- Better liquidityCurrent ratio rose1.37 → 1.74
- No dilutionShare count did not rise690M → 677M
- Gross margin improvedGross margin up on the prior year35.71% → 36.13%
- More efficientAsset turnover rose0.75 → 0.74
See a number that looks wrong?